Crossmark

Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1

Crossref DOI link: https://doi.org/10.1038/s41379-021-00906-7

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Morini, Aurélien

Drossart, Tom

Timsit, Marc-Olivier

Sibony, Mathilde

Vasiliu, Viorel

Gimenez-Roqueplo, Anne-Paule https://orcid.org/0000-0002-4816-670X
Favier, Judith https://orcid.org/0000-0001-8190-5853
Badoual, Cécile

Mejean, Arnaud

Burnichon, Nelly

Verkarre, Virginie https://orcid.org/0000-0001-7720-0236
Funding

Funding for this research was provided by:

Fondation ARC pour la Recherche sur le Cancer (PGA1 RF20190208466)

Fondation ARC pour la Recherche sur le Cancer (PGA1 RF20190208466)

Fondation ARC pour la Recherche sur le Cancer (PGA1 RF20190208466)

Fondation ARC pour la Recherche sur le Cancer (PGA1 RF20190208466)

Fondation ARC pour la Recherche sur le Cancer (PGA1 RF20190208466)
License Information

Text and Data Mining valid from 2022-03-01

Text and Data Mining valid from 2022-03-01

Version of Record valid from 2023-03-01
More Information

This article is maintained by: Elsevier

Article Title: Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1

Journal Title: Modern Pathology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-021-00906-7

Content Type: article

Copyright: © 2021 United States & Canadian Academy of Pathology.